These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30517121)

  • 21. Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences?
    Salvetti M; Paini A; Andreoli L; Stassaldi D; Aggiusti C; Bertacchini F; Rosei CA; Piantoni S; Franceschini F; Tincani A; Muiesan ML
    Eur J Intern Med; 2020 Mar; 73():76-82. PubMed ID: 31831254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus.
    Flynn A; Gilhooley E; O'Shea F; Wynne B
    Clin Rheumatol; 2018 Mar; 37(3):817-818. PubMed ID: 29392510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
    Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Goldsmith CH; Fortin P; Ginzler E; Gordon C; Hanly JG; Isenberg DA; Kalunian K; Nived O; Petri M; Sanchez-Guerrero J; Snaith M; Sturfelt G
    Arthritis Rheum; 1997 May; 40(5):809-13. PubMed ID: 9153540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Vascular Aging in Normotensive Patients With Systemic Lupus Erythematosus: Comparison With Young Patients Having Hypertension.
    Morreale M; Mulè G; Ferrante A; D'ignoto F; Cottone S
    Angiology; 2016 Aug; 67(7):676-82. PubMed ID: 26535012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Subtypes of Microparticle-containing Immune Complexes Are Associated with Disease Activity, Damage, and Carotid Intima-media Thickness in Systemic Lupus Erythematosus.
    Fortin PR; Cloutier N; Bissonnette V; Aghdassi E; Eder L; Simonyan D; Laflamme N; Boilard E
    J Rheumatol; 2016 Nov; 43(11):2019-2025. PubMed ID: 27585687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus.
    Castejon R; Jimenez-Ortiz C; Valero-Gonzalez S; Rosado S; Mellor S; Yebra-Bango M
    Rheumatology (Oxford); 2014 Apr; 53(4):631-8. PubMed ID: 24273021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
    Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ
    PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis.
    Sánchez-Pérez H; Tejera-Segura B; de Vera-González A; González-Delgado A; Olmos JM; Hernández JL; Corrales A; López-Mejías R; González-Gay MA; Ferraz-Amaro I
    Clin Exp Rheumatol; 2017; 35(6):885-892. PubMed ID: 28281456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus.
    Medeiros PBS; Salomão RG; Teixeira SR; Rassi DM; Rodrigues L; Aragon DC; Fassini PG; Ued FV; Tostes RC; Monteiro JP; Ferriani VPL; de Carvalho LM
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):35. PubMed ID: 33743717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
    Nossent JC
    J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus.
    Kay SD; Poulsen MK; Diederichsen AC; Voss A
    J Rheumatol; 2016 Feb; 43(2):315-22. PubMed ID: 26628595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).
    Oku K; Atsumi T; Akiyama Y; Amano H; Azuma N; Bohgaki T; Asanuma YF; Horita T; Hosoya T; Ichinose K; Kato M; Katsumata Y; Kawaguchi Y; Kawakami A; Koga T; Kohsaka H; Kondo Y; Kubo K; Kuwana M; Mimori A; Mimori T; Mimura T; Murakami K; Nakano K; Nakayamada S; Ogishima H; Ohmura K; Saito K; Sano H; Shibuya M; Takahashi Y; Takasaki Y; Takeuchi T; Tamura N; Tanaka Y; Tsuboi H; Tsunoda S; Yukawa N; Yamakawa N; Yamamoto K; Sumida T
    Mod Rheumatol; 2018 Jul; 28(4):642-648. PubMed ID: 29120258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients.
    Mercurio V; Lobasso A; Barbieri L; Parrella P; Ciervo D; Liccardo B; Bonaduce D; Tocchetti CG; De Paulis A; Rossi FW
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head.
    Barinotti A; Radin M; Cecchi I; Foddai SG; Arbrile M; Rubini E; Menegatti E; Roccatello D; Sciascia S
    Int J Cardiol; 2022 Sep; 363():185-189. PubMed ID: 35714714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.
    Manzi S; Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Rairie JE; Tracy RP; Kuller LH
    Arthritis Rheum; 1999 Jan; 42(1):51-60. PubMed ID: 9920014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QRISK3-based analysis of cardiovascular risk factors in patients with long-term but well-controlled systemic lupus erythematosus.
    Wang SL; Li W; Li TF; Liang X; Yan YL; Liu SY
    Am J Transl Res; 2022; 14(5):3247-3260. PubMed ID: 35702101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.